EUVIMED · CrossrefZeitschrift
Neuropsychiatric Disease and Treatment
ISSN 1176-6328 · Informa UK Limited
Neueste Artikel
More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997–2013
Temperament, character traits, and alexithymia in patients with panic disorder
Mental health and burnout in primary and secondary school teachers in the remote mountain areas of Guangdong Province in the People's Republic of China
Quality of life measurement and outcome in aphasia
Risk factors for fatal and nonfatal repetition of suicide attempts: a literature review
Effects of ozone applied by spinal endoscopy in patients with chronic pain related to failed back surgery syndrome: a pilot study
Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia–Pacific survey
The relationship between self-disgust, guilt, and flow experience among Japanese undergraduates
Profile of blonanserin for the treatment of schizophrenia
Maturation of the adolescent brain
Worsened hypertension control induced by aripiprazole
Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
Help-seeking behavior among Japanese school students who self-harm: results from a self-report survey of 18,104 adolescents
Transdermal donepezil on the treatment of Alzheimer's disease
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
The noradrenergic symptom cluster: clinical expression and neuropharmacology
Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
The importance of norepinephrine in depression
Cognitive behavioral therapy for the treatment of post-traumatic stress disorder: a review
Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo®)
Distinguishing between attention-deficit hyperactivity and fetal alcohol spectrum disorders in children: clinical guidelines
Management of refractory complex partial seizures: current state of the art
Prophylaxis of migraine: general principles and patient acceptance
Treatment of Lennox-Gastaut syndrome: overview and recent findings
Current approaches to the treatment of Parkinson’s disease
Tiagabine: efficacy and safety in partial seizures – current status
Zebrafish: An in vivo model for the study of neurological diseases
EUVIMED